Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gum Tech

This article was originally published in The Tan Sheet

Executive Summary

Second quarter sales decline 24% to $1.4 mil. due to lower Zicam Allergy Relief revenues resulting from "high level of inventory held by retailers" prior to Q2 and "substantial introductory sales recorded in 2000," company announces Aug. 14. Sales for first six months increased 60% to $7.8 mil. from year-ago period. Phoenix-based firm reports Q2 net loss of $2.3 mil., citing "significant impact" due to settlement, legal costs due to patent infringement lawsuit brought by Quigley (1"The Tan Sheet" June 11, In Brief)

You may also be interested in...



Gel Tech

Zicam marketer to pay Quigley $1.1 mil. and 5.5% royalty on cold remedy sales from April 1, 2000 to March 5, 2002, with minimum royalty payment of $500,000, under settlement of Cold-Eeze zinc lozenges marketer's patent infringement lawsuit on fourth day of trial in Philadelphia federal court June 7. Quigley sued Gel Tech in November 1999, alleging Zicam homeopathic zinc nasal spray infringed its '465 patent covering application of zinc gluconate to virus-infected tissue to reduce duration of common cold

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS092930

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel